~~<i id='1AC00E91A5'><strike id='1AC00E91A5'><tt id='1AC00E91A5'><pre id='1AC00E91A5'></pre></tt></strike></i>~~

Home» explore» fashion

fashion

author：focus 2025-09-28 13:02:12 Page View：49

A new Ebola epidemic in the Democratic Republic of the Congo is shaping up to be the most dangerous and difficult test of the world’s ability to contain the disease since the catastrophic West African outbreak in 2014 and 2015. What challenges are responders facing? And how might experimental vaccines be used to try to slow the spread of the epidemic?

See below for an archived chat with Helen Branswell about these issues and more.

Previous article： Why CTE doesn’t keep Americans from enjoying the Super Bowl
Next article： At least 13 dead in Texas as scorching temps continue

explore

Novavax promises a turnaround & Lilly roils the obesity market

SammyKimballforSTATCanNovavaxfinallygetitright?What’sa“triple-G”drug?AndisNovoNordisklosingground?We

Unique patient identifier: Experts argue the benefits, pitfalls

Therehasbeenlong-standingdebateintheUSoverwhethertoimplementauniquepatientidentifiersystem.EvanVucci

After affirmative action ruling, medical educators look to 'holistic review'

AnnaMoneymaker/GettyImagesAfterhavingadaytoreadthroughtheSupremeCourt’sdecisiononaffirmativeaction,s

Readout Newsletter: Geron, Novo Nordisk, WuXi updates

KayanaSzymczakforSTATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiote